Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Submitted to the 35th Annual Meeting Council on Arteriosclerosis American Society for the Study of Arteriosclerosis Dallas, Texas, November 1981

Submitted to the 35th Annual Meeting Council on Arteriosclerosis American Society for the Study... Abstracts Submitted to the 35th Annual Meeting Council on Arteriosclerosis American Society for the Study of Arteriosclerosis Dallas, Texas, November 1981 •Antiatherogenic Effect of Nifedipine in Cholesterol- Fed Rabbit Page Table of Contents K. I. Bentley and P. D. Henry, Washington University, 353 Arterial Wall St. Louis, MO 358 Cell Biology Calcium may play an important role in mediating athero- 362 Cholesterol Metabolism sclerotic vascular injury. To determine whether Ca++-antago- ++ nists, potent inhibitors of Ca uptake by smooth muscle, 373 Lipoprotein Metabolism exert antiatherogenic effects, rabbits (n = 28) were placed on 390 Lipoprotein Structure 2% cholesterol pellets and assigned randomly to a placebo group (P) or a group (N) receiving daily 40 mg of nifedipine Stars indicate papers presented at the meeting. p.o. Nifedipine produced only small, transient decreases in Authors Index is at the end of the Abstracts. arterial pressure (peak = —11 ± 1 mm Hg; SE; n = 7). After 8 weeks, mean values ± SE (n = 13) for body weight, hemato- crit, total serum cholesterol, serum Ca++, and serum protein were 3.30 ± .10 kg, 33 ± 2%, 1903 ± 207 mg/dl, 13.0 ± .02 mg/dl and 5.2 ± .1 g/dl in http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Arteriosclerosis Wolters Kluwer Health

Submitted to the 35th Annual Meeting Council on Arteriosclerosis American Society for the Study of Arteriosclerosis Dallas, Texas, November 1981

Arteriosclerosis , Volume 1 (5) – Sep 1, 1981

Loading next page...
 
/lp/wolters-kluwer-health/submitted-to-the-35th-annual-meeting-council-on-arteriosclerosis-6RIu0hBIt2
Copyright
© 1981 by American Heart Association, Inc.
ISSN
0276-5047

Abstract

Abstracts Submitted to the 35th Annual Meeting Council on Arteriosclerosis American Society for the Study of Arteriosclerosis Dallas, Texas, November 1981 •Antiatherogenic Effect of Nifedipine in Cholesterol- Fed Rabbit Page Table of Contents K. I. Bentley and P. D. Henry, Washington University, 353 Arterial Wall St. Louis, MO 358 Cell Biology Calcium may play an important role in mediating athero- 362 Cholesterol Metabolism sclerotic vascular injury. To determine whether Ca++-antago- ++ nists, potent inhibitors of Ca uptake by smooth muscle, 373 Lipoprotein Metabolism exert antiatherogenic effects, rabbits (n = 28) were placed on 390 Lipoprotein Structure 2% cholesterol pellets and assigned randomly to a placebo group (P) or a group (N) receiving daily 40 mg of nifedipine Stars indicate papers presented at the meeting. p.o. Nifedipine produced only small, transient decreases in Authors Index is at the end of the Abstracts. arterial pressure (peak = —11 ± 1 mm Hg; SE; n = 7). After 8 weeks, mean values ± SE (n = 13) for body weight, hemato- crit, total serum cholesterol, serum Ca++, and serum protein were 3.30 ± .10 kg, 33 ± 2%, 1903 ± 207 mg/dl, 13.0 ± .02 mg/dl and 5.2 ± .1 g/dl in

Journal

ArteriosclerosisWolters Kluwer Health

Published: Sep 1, 1981

There are no references for this article.